Search - tctmd.com

Displaying 21 - 40 of 76

Sort: Relevancy | Date

SHAM-PVI Catheter Ablation Improves Objective Measure of AF Burden

News Conference News ESC 2024

SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden

September 02, 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presentation ESC 2024

The SHAM-PVI Study: A randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation

Presenter: Rick Veasey

September 02, 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presentation ESC 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presenter: Masaharu Masuda

September 02, 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

News Conference News ESC 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

September 02, 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

September 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

September 01, 2024

A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation on Cardiovascular Outcomes in Rural China

Presentation ESC 2024

A Novel Model of Integrated Care of Older Patients With Atrial Fibrillation on Cardiovascular Outcomes in Rural China

Presenter: Minglong Chen

September 01, 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presentation ESC 2024

Stroke prevention & rhythm control Therapy: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation

Presenter: Dipak Kotecha

September 01, 2024

Randomized invitation to systematic NT-proBNP and ECG screening in 75- year olds to detect atrial fibrillation – STROKESTOP II

Presentation ESC 2024

Randomized invitation to systematic NT-proBNP and ECG screening in 75- year olds to detect atrial fibrillation – STROKESTOP II

Presenter: Katrin Kemp Gudmundsdottir

September 01, 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

September 01, 2024

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

News Daily News

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

August 27, 2024

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

AF After Cardiac Surgery More Likely in Men, More Deadly in Women

News Daily News

AF After Cardiac Surgery More Likely in Men, More Deadly in Women

Yael L. Maxwell

August 21, 2024

August 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

August 01, 2024

Registry Data Reassure on Safety With Next-Generation Watchman Device

News Daily News

Registry Data Reassure on Safety With Next-Generation Watchman Device

July 30, 2024

Constellations of Sleep Issues Can Point to Patients at Risk for AF

News Daily News

Constellations of Sleep Issues Can Point to Patients at Risk for AF

July 17, 2024

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

News Daily News

Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis

July 12, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.